Market Tracker

07/30 6:05pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

During the Trading Day
6.23 +0.315 / +5.33%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.23 0.00 / 0.00%
 
Volume: 14.3K
No recent news for Merrimack Pharmaceuticals Inc.

Today’s Trading

Previous close5.92
Today’s open6.00
Day’s range5.99 - 6.23
Volume1,304,538
Average volume (3 months)2,349,534
Market cap$611.6M
Dividend yield--
Data as of 3:59pm ET, 07/30/2014

Growth & Valuation

Earnings growth (last year)-5.32%
Earnings growth (this year)+12.25%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-2.32%
P/E ratioNM
Price/Sales11.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma Inc+0.64+7.80%
NLNKNewLink Genetics Cor...+1.06+4.87%
OREXOrexigen Therapeutic...-0.11-2.12%
MGNXMacroGenics Inc-0.03-0.14%
Data as of 3:59pm ET, 07/30/2014

Financials

Next reporting dateAugust 8, 2014
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$47.8M
Annual profit (last year)-$130.9M
Net profit margin-273.98%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Senior Vice President-
Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts